Illumina (ILMN)
(Delayed Data from NSDQ)
$153.49 USD
+3.73 (2.49%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $150.00 -3.49 (-2.27%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$153.49 USD
+3.73 (2.49%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $150.00 -3.49 (-2.27%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Five Runaway Breakout Stocks to Buy
by David Bartosiak
With the market at all-time highs again, the rich get richer as stocks continue to breakout.
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $358.08 in the latest trading session, marking a +0.1% move from the prior day.
Why These Innovative Biotech ETFs Are Soaring
by Neena Mishra
Strong M&A activity has sent shares of many small, innovative biotech companies surging
The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints
by Nalak Das
The Fed has said that adoption of more accommodative policy is gaining ground as some economic developments raised concerns about U.S. and global growth.
46 and You: Genetic Testing = Giant Growth Market
by Kevin Cook
Advances in genomic diagnostic technology have made testing affordable for the 99.0% of the world still in line.
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $347.53, moving -1.02% from the previous trading session.
Moving Average Crossover Alert: Illumina
by Zacks Equity Research
Illumina, Inc. (ILMN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
GILD vs. ILMN: Which Stock Is the Better Value Option?
by Zacks Equity Research
GILD vs. ILMN: Which Stock Is the Better Value Option?
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion
by Zacks Equity Research
Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $339.15, moving +0.97% from the previous trading session.
The Zacks Analyst Blog Highlights: American International, Arconic, Hasbro, Illumina and Jefferies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: American International, Arconic, Hasbro, Illumina and Jefferies
5 Top S&P 500 Stocks to Fly High Despite Market Volatility
by Nalak Das
The S&P 500 Index recovered the lost ground to a large extent with a gain of 4.4% in the first week of June.
Illumina (ILMN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $318.56, moving +0.13% from the previous trading session.
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne
5 Biotech Stocks to Buy Right Now
by Zachary Stutler
here are a few stocks that have outperformed their peers and are expected to have continued growth throughout the next couple of years. All the stocks in this list are a Zacks Rank #2 (Buy) or better.
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
by Zacks Equity Research
Sector ETF report for PBE
GILD or ILMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GILD vs. ILMN: Which Stock Is the Better Value Option?
Why Illumina (ILMN) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Illumina (ILMN).
Illumina, Wix.com, Microsoft, Facebook and Oracle highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Illumina, Wix.com, Microsoft, Facebook and Oracle highlighted as Zacks Bull and Bear of the Day
The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer
Bull of the Day: Illumina (ILMN)
by Kevin Cook
The NASA of biotech is helping the world explore crucial genetic information to understand ancestry and disease
Illumina (ILMN) Down 2.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Stocks to Win Big in the Fight Against Cancer
by Tirthankar Chakraborty
We highlight three stocks that are using innovative ways to treat cancer, also called malignancy. These stocks are also great long-term investments.